Latest Tax Incentives News

Page 3 of 64
HITIQ has expanded its military research ambitions and added fresh funding during the September quarter, but the company ended the period with $658,242 in cash and estimated funding for only one quarter. Its US collaboration remains non-binding, leaving financing and commercial execution as the immediate tests.
Victor Sage
Victor Sage
30 Oct 2026
Decidr AI Industries reported a sharp quarterly fall in its invoicing-based AER, even as customer receipts reached a record and Sugarwork’s qualified pipeline expanded. The company is relying on A$11 million of annualised cost reductions and upcoming product launches to extend its runway and convert enterprise interest into recurring revenue.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Nanollose has narrowed its microbial cellulose scale-up plan to one company-controlled Western Australian pilot facility, with all Stage 1 equipment ordered and paid for. The progress comes with a clear funding constraint: the ASX-listed biomaterials developer ended September with $758,000 in cash, equivalent to 1.41 quarters of funding at its current operating burn.
Victor Sage
Victor Sage
30 Oct 2026
Bio-Gene Technology has moved closer to two commercialisation milestones, with Qcide product work progressing in Japan and a first Flavocide regulatory submission targeted for Q2 2027. The company ended September with A$2.103 million in cash, equivalent to an estimated 2.18 quarters of funding at the quarter’s operating cash rate.
Victor Sage
Victor Sage
30 Oct 2026
Iondrive’s updated model points to a US$243 million post-tax NPV for its proposed Oklahoma rare earth module, but the headline economics now face their first substantial bulk-scale test. The company is targeting 1.4 tonnes of mixed rare earth oxides from a North American qualification campaign while pursuing debt, grants and incentives.
Victor Sage
Victor Sage
30 Oct 2026
Nexalis Therapeutics ended September with $371,000 in cash, equivalent to just 0.9 quarters of funding at its recent operating burn. The company has settled its dispute with Linlithgow Family Office, but its clinical programs remain paused while it pursues R&D tax funding and a new capital raise.
Ada Torres
Ada Torres
30 Oct 2026
xReality Group expanded its Operator XR customer base, recurring revenue and sales pipeline in the first quarter, while securing its first US Marine Corps order after quarter end. But the company remains focused on completing its FY26 audit and reinstating trading, with $1.4 million in quarter-end cash against $4.55 million of secured debt.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Australian Rare Earths has produced its first Mixed Rare Earth Hydroxide at the Koppamurra pilot plant while extending an interpreted carbonatite system at Overland by roughly 5km. The operating progress comes with two important qualifiers: Koppamurra still needs further product refinement and Overland assays remain pending.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Blue Energy is positioning its Queensland gas portfolio for potential demand from LNG exporters under proposed federal reservation rules, while seeking a farm-in partner for ATP 854. The company ended September with A$3.2 million in unaudited cash, no debt and a more cautious approach to Sapphire spending.
Victor Sage
Victor Sage
30 Oct 2026
Clever Culture Systems has started FY27 with three APAS Independence sales to Novo Nordisk and AstraZeneca, while targeting eight first-half sales and evaluations. The sales momentum comes with $1.6 million of unsecured loans due in December and a proposed extension still to be secured.
Victor Sage
Victor Sage
30 Oct 2026
Murray Cod Australia has posted record quarterly sales and expanded into hundreds of Woolworths and Coles stores, but the growth story still depends on turning distribution gains into recurring cash receipts. Underlying operating cash outflow remained A$4.27 million after excluding a one-off R&D tax incentive, while August fish mortality exposed an operational risk.
Victor Sage
Victor Sage
30 Oct 2026
Swift TV expanded its contracted footprint and qualified pipeline in the September quarter, but ended with $1.047 million in cash and only 0.9 quarters of funding at the reported burn rate. The company is relying on customer receipts, an expected $1.5 million R&D incentive and lending arrangements as commercial deployments accelerate.
Sophie Babbage
Sophie Babbage
30 Oct 2026

Browse the archive

Full archive